This topic contains a solution. Click here to go to the answer

Author Question: The patient is being treated with an alkylating agent as a chemotherapeutic medication. Which ... (Read 37 times)

audragclark

  • Hero Member
  • *****
  • Posts: 579
The patient is being treated with an alkylating agent as a chemotherapeutic medication. Which drug-induced dermatologic reactions should she be instructed to expect to experience to some degree?
 
  a. Urticaria
  b. Photosensitivity
  c. Alopecia
  d. Purpura

Question 2

A patient is receiving the ocular drug cromolyn (Crolom). Which of the following conditions would the health care provider expect to see in this patient's medical history?
 
  a. Glaucoma
  b. Cataracts
  c. Detachment of the retina
  d. Seasonal allergic conjunctivitis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chou

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

ANS: C
Alkylating agents are known to produce alopecia as a drug-induced dermatologic reaction.

Answer to Question 2

ANS: D
Ocular antihistamines such as cromolyn are used in the management of seasonal allergic conjunc-tivitis as well as vernal keratoconjunctiviti s.




Chou

  • Sr. Member
  • ****
  • Posts: 335

 

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

For a complete list of videos, visit our video library